GL1X · GenesisL1 explorer

MolNFT v1 · #85354 · protein

Crystal structure of human CHK2 in complex with benzimidazole carboxamide inhibitor

4A9U · SERINE/THREONINE-protein kinase CHK2: “Crystal structure of human CHK2 in complex with benzimidazole carboxamide inhibitor”. X-ray diffraction, 3 ligands (A9U, NO3, CL), 3 pockets (best druggability 0.55). MolNFT v1 #85354 on…

PDB
4A9U
Type
protein
Length
287 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
A9U, NO3, CL
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28743% helix, 17% strandO96017

Ligands and binding sites

  • A9U · 2-{4-[(1-benzylpiperidin-4-yl)methoxy]phenyl}-1H-benzimidazole-6-carboxamide · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A
  • CL · Chloride ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11850.550.7934A9U
2920.320.7322empty
3700.290.7319empty

Compared structures

  • 4A9U · Crystal structure of human CHK2 in complex with benzimidazole carboxamide inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.